title: Access to scientific publications: the scientist's perspective.
abstract: BACKGROUND
  Scientific publishing is undergoing significant changes due to the growth of online publications, increases in the number of open access journals, and policies of funders and universities requiring authors to ensure that their publications become publicly accessible. Most studies of the impact of these changes have focused on the growth of articles available through open access or the number of open-access journals. Here, we investigated access to publications at a number of institutes and universities around the world, focusing on publications in HIV vaccine research--an area of biomedical research with special importance to the developing world.
  
  
  RESULTS
  We selected research papers in HIV vaccine research field, creating: 1) a first set of 50 most recently published papers with keywords "HIV vaccine" and 2) a second set of 200 articles randomly selected from those cited in the first set. Access to the majority (80%) of the recently published articles required subscription, while cited literature was much more accessible (67% freely available online). Subscriptions at a number of institutions around the world were assessed for providing access to subscription-only articles from the two sets. The access levels varied widely, ranging among institutions from 20% to 90%. Through the WHO-supported HINARI program, institutes in low-income countries had access comparable to that of institutes in the North. Finally, we examined the response rates for reprint requests sent to corresponding authors, a method commonly used before internet access became widespread. Contacting corresponding authors with requests for electronic copies of articles by email resulted in a 55-60% success rate, although in some cases it took up to 1.5 months to get a response.
  
  
  CONCLUSIONS
  While research articles are increasingly available on the internet in open access format, institutional subscriptions continue to play an important role. However, subscriptions do not provide access to the full range of HIV vaccine research literature. Access to papers through subscriptions is complemented by a variety of other means, including emailing corresponding authors, joint affiliations, use of someone else's login information and posting requests on message boards. This complex picture makes it difficult to assess the real ability of scientists to access literature, but the observed differences in access levels between institutions suggest an unlevel playing field, in which some researchers have to spend more efforts than others to obtain the same information.
authors: Global HIV Vaccine Enterprise, New York, New York, United States of America. yvoronin@vaccineenterprise.org
authors: Yegor
authors: Y
authors: Voronin
authors: Askar
authors: A
authors: Myrzahmetov
authors: Alan
authors: A
authors: Bernstein
mesh_terms: D022126:Access to Information; D015706:Bibliometrics; D035843:Biomedical Research; D006801:Humans; D020407:Internet / Q000592:standards / Q000706:statistics & numerical data*; D010506:Periodicals as Topic / Q000191:economics / Q000639:trends*